Why Does Insulin Cost So Much? Big Pharma Isnāt the Only Player Driving Prices
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but itās the arbitrators that jack up prices for those who can least afford them.
The independent source for health policy research, polling, and news.
821 - 840 of 1,914 Results
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but itās the arbitrators that jack up prices for those who can least afford them.
States are turning to the big health insurance companies to keep Medicaid enrollees insured once pandemic protections end in April. The insurersā motive: profits.
This installment of InvestigateTV and KHNās āCostly Careā series looks at the case of a New Orleans woman whose thumb injury saddled her with a big ER bill for a tetanus shot and some minor care.
While Medicare was designed as health insurance for those 65 and older, it also covers people with disabilities who are young enough to still get pregnant. Yet they often struggle to get their birth control covered and end up with large medical bills ā or instead opt for hysterectomies or tubal ligations, which Medicare sometimes will cover.
Consumer and patient advocates push for new federal rules to protect Americans from debt collectors and force hospitals to make financial assistance more accessible.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Hereās a collection of their appearances.
President Joe Biden and Republicans in Congress spent last month sparring over whether to shield Medicare and Social Security from budget cuts ā leading some to wonder if Medicaid was on the table instead. Biden and Democrats say no, but some Republicans seem eager to trim federal spending on the health program for Americans with low incomes. And ready or not, artificial intelligence is coming to medical care. Benefits, as well as unintended consequences, are likely. Alice Miranda Ollstein of Politico, Rachel Cohrs of STAT News, and Lauren Weber of The Washington Post join KHNās chief Washington correspondent, Julie Rovner, to discuss these issues and more.
Eli Lilly's news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
More than 10,000 dental patients have been fitted with an Anterior Growth Guidance Appliance, or AGGA, according to court records.Ā But the unproven and unregulated device has not been evaluated by the FDA, according toĀ a months-long joint investigation by KHN and CBS News.
Medi-Cal serves more than one-third of the stateās population ā offering a dizzying range of care to a diverse population. In the new āFaces of Medi-Calā series, California Healthline will assess the programās strengths and weaknesses through the lives and experiences of its enrollees.
States take drastically different approaches to recovering Medicaid money from deceased participantsā estates. Demands for repayment of Medicaid spending can drain the assets a person leaves behind, depending on where they lived.
A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGAās inventor and manufacturer have denied all liability in court.
As many lower-income Americans prepare to lose pandemic-era access to Medicaid, President Joe Biden vowed to stop Republicans from making deeper cuts to lower the national debt. Other changes may still be up for discussion.
Billing experts and lawmakers are playing catch-up as providers find ways to get around new surprise-billing laws, leaving patients like Danielle Laskey of Washington state with big bills for emergency care.
Coloradoās proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
Gov. Gavin Newsom is winding down state assistance for health care services to migrants seeking asylum. Heās lobbying the Biden administration to increase aid along the stateās southern border.
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics arenāt always the lowest-priced deal.
A listener sued a hospital in small-claims court and lost but felt as if sheād won. Now, she wants to encourage more people to take their bills to court.
The first installment of InvestigateTV and KHNās āCostly Careā series explores one California motherās experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
Ā© 2026 KFF